These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14699401)

  • 21. Regulation of NF-kappaB action by reversible acetylation.
    Greene WC; Chen LF
    Novartis Found Symp; 2004; 259():208-17; discussion 218-25. PubMed ID: 15171256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing acetylation of NF-kappaB.
    Chen LF; Greene WC
    Methods; 2005 Aug; 36(4):368-75. PubMed ID: 16111893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of NF-kappaB/I kappa B alpha in N-methyl-N-nitrosourea-induced retinal damage in rats].
    Yang JN; Zhan HQ; Chen JM; Lin SC; Li D; Hu SX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):603-5. PubMed ID: 16762860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
    Viatour P; Merville MP; Bours V; Chariot A
    Trends Biochem Sci; 2005 Jan; 30(1):43-52. PubMed ID: 15653325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of humoral immune response and activation of NF-kappaB pathway in lymphocytes in experimentally induced hyperthyroid rats.
    Vinayagamoorthi R; Koner BC; Kavitha S; Nandakumar DN; Padma Priya P; Goswami K
    Cell Immunol; 2005 Nov; 238(1):56-60. PubMed ID: 16472792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of NF-kappaB by elongation factors is determined by core promoter type.
    Amir-Zilberstein L; Ainbinder E; Toube L; Yamaguchi Y; Handa H; Dikstein R
    Mol Cell Biol; 2007 Jul; 27(14):5246-59. PubMed ID: 17502349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of death receptor signaling by bacterial gut pathogens.
    Giogha C; Lung TW; Pearson JS; Hartland EL
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):235-43. PubMed ID: 24440054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GogB is an anti-inflammatory effector that limits tissue damage during Salmonella infection through interaction with human FBXO22 and Skp1.
    Pilar AV; Reid-Yu SA; Cooper CA; Mulder DT; Coombes BK
    PLoS Pathog; 2012; 8(6):e1002773. PubMed ID: 22761574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A CLA's act: feeding away inflammation.
    Greicius G; Arulampalam V; Pettersson S
    Gastroenterology; 2004 Sep; 127(3):994-6. PubMed ID: 15362056
    [No Abstract]   [Full Text] [Related]  

  • 30. NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases.
    Schmid RM; Adler G
    Gastroenterology; 2000 Jun; 118(6):1208-28. PubMed ID: 10833496
    [No Abstract]   [Full Text] [Related]  

  • 31. Tuning down NF-kappaB signaling by DUBs: a fly case.
    Leulier F
    Cell Host Microbe; 2009 Oct; 6(4):294-6. PubMed ID: 19837367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SHP works a double shift to control TLR signaling.
    Beyaert R
    Nat Immunol; 2011 Jul; 12(8):725-7. PubMed ID: 21772282
    [No Abstract]   [Full Text] [Related]  

  • 33. Bugs inside Bugs: what the fruit fly can teach us about immune and microbial balance in the gut.
    Muyskens JB; Guillemin K
    Cell Host Microbe; 2008 Mar; 3(3):117-8. PubMed ID: 18329607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of enhanced eosinophil survival in inflammation.
    Zimmermann N; Rothenberg ME
    Blood; 2015 Jun; 125(25):3831-2. PubMed ID: 26089379
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of adaptive immune responses: a novel mechanism by which peroxisome proliferators exert antiinflammatory effects?
    Yang Q; Xie Y; DePierre JW
    Ann N Y Acad Sci; 2002 Nov; 973():13-6. PubMed ID: 12485827
    [No Abstract]   [Full Text] [Related]  

  • 36. PPARs: altering clinical responses in Type 2 diabetes and atherosclerosis. Introduction.
    Plutzky J
    Clin Cardiol; 2004 Jul; 27(7 Suppl 4):IV1-2. PubMed ID: 15470904
    [No Abstract]   [Full Text] [Related]  

  • 37. Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review.
    Barandouzi ZA; Rowcliffe C; Schrogin J; Meador R; Bruner DW
    Support Care Cancer; 2022 Aug; 30(8):6497-6513. PubMed ID: 35396962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiome and Its Associations With Acute and Chronic Gastrointestinal Toxicities in Cancer Patients With Pelvic Radiation Therapy: A Systematic Review.
    Bai J; Barandouzi ZA; Rowcliffe C; Meador R; Tsementzi D; Bruner DW
    Front Oncol; 2021; 11():745262. PubMed ID: 34938654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositis.
    Zhang T; Lu SH; Bi Q; Liang L; Wang YF; Yang XX; Gu W; Yu J
    Front Pharmacol; 2017; 8():786. PubMed ID: 29170638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nickel(II) complex of polyhydroxybenzaldehyde N4-thiosemicarbazone exhibits anti-inflammatory activity by inhibiting NF-κB transactivation.
    Shawish HB; Wong WY; Wong YL; Loh SW; Looi CY; Hassandarvish P; Phan AY; Wong WF; Wang H; Paterson IC; Ea CK; Mustafa MR; Maah MJ
    PLoS One; 2014; 9(6):e100933. PubMed ID: 24977407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.